Monoclonal Antibody Therapeutic (Centivax)

N/A

Report date: 2026/01/04 09:59:56

Base Information

Drug NameMonoclonal Antibody Therapeutic (Centivax)
Drug Alias Namemonoclonal antibody therapeutic (Centivax)centi-B9 (Centivax)Centi-B9
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentivax Inc
China Registration ClassN/A

Develop Information

Active CompaniesCentivax Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A